Insider Profile
Friedmann, Lance
1
Companies Filed At
0
Open-Market Buys (2yr)
—
Buy Value (2yr, open-market)
Jun 23, 2023
Most Recent Trade
14
Credibility
Score
18%
Hit Rate
-15.9%
Avg 90d Return
-14.3%
Median 90d Return
17
Evaluated Trades
+36.1%
Best Trade
-55.6%
Worst Trade
Hit rate and returns are based on 17 open-market buys with evaluable 90-day outcomes. Score reflects historical conviction, not a guarantee of future performance. Limited signal — either below-average timing or insufficient trade history.
Date Company Role Nature Dir. Shares Price Value Score
Jun 23, 2023 $ACB
Aurora Cannabis
— Comp. Grant Buy 49,342 — — 10
Feb 28, 2023 $ACB
Aurora Cannabis
— Comp. Grant Buy 32,327 — — 10
Dec 31, 2022 $ACB
Aurora Cannabis
— Plan / DRIP Buy 34,272 — — 10
Sep 30, 2022 $ACB
Aurora Cannabis
— Comp. Grant Buy 27,083 — — 10
Sep 30, 2022 $ACB
Aurora Cannabis
— Comp. Grant Buy 7,859 — — 10
Feb 28, 2022 $ACB
Aurora Cannabis
— Comp. Grant Buy 2,700 — — 10
Feb 28, 2022 $ACB
Aurora Cannabis
— Comp. Grant Buy 9,447 — — 10
Feb 28, 2021 $ACB
Aurora Cannabis
— Comp. Grant Buy 2,837 — — 10
Feb 28, 2021 $ACB
Aurora Cannabis
— Comp. Grant Buy 975 — — 10
Nov 30, 2020 $ACB
Aurora Cannabis
— Comp. Grant Buy 3,371 — — 10
Nov 30, 2020 $ACB
Aurora Cannabis
— Comp. Grant Buy 860 — — 10
Sep 10, 2020 $ACB
Aurora Cannabis
— Comp. Grant Buy 1,301 — — 10
Sep 10, 2020 $ACB
Aurora Cannabis
— Comp. Grant Buy 4,582 — — 10
May 31, 2020 $ACB
Aurora Cannabis
— Comp. Grant Buy 2,131 — — 10
May 31, 2020 $ACB
Aurora Cannabis
— Comp. Grant Buy 681 — — 10
May 11, 2020 $ACB
Aurora Cannabis
— Corp. Event Sell 6,647 — — 10
May 11, 2020 $ACB
Aurora Cannabis
— Corp. Event Sell 20,312 — — 10
Mar 02, 2020 $ACB
Aurora Cannabis
— Comp. Grant Buy 7,251 — — 10
Mar 02, 2020 $ACB
Aurora Cannabis
— Comp. Grant Buy 22,159 — — 10
Muted rows are plan purchases, compensation grants, or DRIP — not open-market. Confluence Scores reflect the company's current score, not the score at time of trade.
Form55 provides data and analysis for informational purposes only. Nothing on this site constitutes investment advice or a recommendation to buy or sell any security. Past performance is not indicative of future results.